Related by context. Frequent words. (Click for all words.) 66 blind randomized placebo 65 double blinded placebo 62 Phase III randomized 62 multicenter randomized double 61 active comparator 61 placebo controlled randomized 61 label dose escalation 61 dose regimens 60 double blind placebo 60 blind randomized 60 blinded placebo controlled 60 placebo controlled clinical 59 randomized Phase III 59 multicenter randomized 59 randomized placebo controlled 59 placebo controlled 58 randomized double 58 prospective randomized controlled 58 dose escalation trial 57 label multicenter 57 randomized controlled 57 pertuzumab 57 pharmacodynamics 56 blind placebo controlled 56 dose cohorts 56 prospective randomized 56 safety tolerability pharmacokinetics 56 Phase 1b clinical 56 Phase 1b trial 56 plus prednisone 56 phase IIb 55 nab paclitaxel 55 deforolimus 55 dose escalation study 55 randomized #:# 55 placebo controlled studies 55 randomized controlled clinical 55 SCH # 54 IMC A# 54 diabetic neuropathic pain 54 mg BID 54 phase 2a 54 randomized 54 Carfilzomib 54 Pivotal Trial 54 placebo controlled trials 54 dosing regimens 54 Pivotal Phase 54 peginterferon alfa 2b 54 relapsed multiple myeloma 53 phase IIa 53 Pegasys R 53 plus gemcitabine 53 dacarbazine 53 tezampanel 53 Phase Ib 53 blind randomized controlled 53 randomized clinical 53 multicenter 53 Phase 2a clinical 53 Sym# 53 FOLFIRI 53 events SAEs 53 RGB # 53 mirtazapine 53 relapsed refractory multiple myeloma 53 HGS ETR1 53 dosing schedules 53 Phase 1b 53 relapsing remitting multiple sclerosis 52 #mg dose [001] 52 Phase 2b clinical 52 investigational oral 52 mg doses 52 multicentre 52 vicriviroc 52 dose limiting toxicities 52 Phase 2b study 52 axitinib 52 ACTEMRA 52 ponatinib 52 AVE# 52 GRN#L 52 events AEs 52 mg QD 52 chronic HCV infection 52 Amrubicin 52 tyrosine kinase inhibitor 52 multicenter clinical 52 Rosuvastatin 52 administered subcutaneously 52 Azedra 52 intravenously administered 52 BMS # 52 dose escalation 51 NGX# 51 BAY #-# 51 ISENTRESS 51 lacosamide 51 bosentan 51 discontinuations due